Abstract
A major priority in many low and middle income countries is the eradication of infectious diseases through an effective vaccination program. However, the lack of reliable infrastructure, equipment and support often prove to be significant barriers in such countries. In particular, unreliable electric power and refrigeration equipment are major concerns and this has prompted research into the development of passive cold storage devices (PCDs) that are not dependent on electric power and can maintain cold temperatures for extended periods of time using a passive medium such as ice. The development of PCDs is in its early stages, and there are many open questions including how they should be sized, the interaction between price and device size, and how often they should be replenished. So far, these types of questions have not been systematically analyzed anywhere in the research literature, and this paper describes a model to address these issues in order to better guide the development of PCDs in the near future. This paper examines actual use cases with real data from a representative country, and presents a model that captures the various tradeoffs that must be considered in developing a suitable PCD while providing guidance on what would constitute a useful, robust and economical design.
Similar content being viewed by others
References
AirContainer Package System (2013). Pre-qualified PCM package system for temperature-sensitive. http://www.aircontainer.com/the-product.aspx. Accessed July 10, 2013.
CIA (2012). The world factbook: Niger. https://www.cia.gov/library/publications/the-world-factbook/geos/ng.html. Accessed July 10, 2013.
Conway, M., et al. (2012). Improving cold chain technologies through the use of phase-change material. University of Maryland, College Park. http://drum.lib.umd.edu/bitstream/1903/12491/1/FRESH.pdf. Accessed July 10, 2013.
Dometic (2013). RCW 4. http://www.dometic.com/enlu/Europe/Luxembourg/Medical-Systems/Cold-Chain/Transport-Boxes/products/?productdataid=79144. Accessed July 10, 2013.
Gasperino, D., & Yildirim, O. (2011). Design and prototyping of a passive cold chain vaccine storage device for long hold times. In Comsol conference: intellectual ventures, Boston, MA.
GAVI-1 (2011). GAVI alliance: country hub. http://www.gavialliance.org/country/. Accessed July 10, 2013.
GAVI-2 (2012). Niger: GAVI alliance. http://www.gavialliance.org/country/niger/. Accessed July 10, 2013.
Intellectual Ventures (2013). Vaccine cold chain device. http://www.intellectualventures.com/index.php/inventions-patents/our-inventions/vaccine-cold-chain-device. Accessed July 10, 2013
Jamison, D., Breman, J., Measham, A., Alleyne, G., Claeson, M., Evans, D., Jha, P., Mills, A., & Musgrove, P. (2006). Disease control priorities in developing countries (2nd ed.). New York: Oxford University Press.
Kaufmann, J. R., Miller, R., & Cheyne, J. (2011). Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Affairs, 30(6), 1113–1121.
Kouvelis, P., & Yu, G. (1997). Robust discrete optimization and its applications. New York: Kluwer Academic.
Lee, B. Y., Norman, B. A., Assi, T. M., Chen, S. I., Bailey, R. R., Rajgopal, J., Brown, S. T., Wiringa, A. E., & Burke, D. S. (2010). Single versus multi-dose vaccine vials: an economic computational model. Vaccine, 28(32), 5292–5300.
Laxminarayan, R., & Ganguly, N. K. (2011). India’s vaccine deficit: why more than half of Indian children are not fully immunized, and what can—and should—be done. Health Affairs, 30(6), 1096–1103.
McCarney, S. (2009). RFP for new insulated containers and carriers for vaccine. http://www.technet-21.org/index.php/component/content/article/95-articles/forums/1500-topic1533. Accessed July 10, 2013.
McClean, K., Melgen, S., Poole, J., Shroff, P., & Wiggins, C. (2010). Thinking outside the (cool) box. Georgia Tech, Atlanta. http://www-old.me.gatech.edu/jonathan.colton/detm/coolboxfinalreport.pdf. Accessed July 10, 2013.
Project Optimize (2013). Unplugged and keeping cool—testing off-grid vaccine storage solutions in Vietnam. PATH/WHO: Seattle/Washington. http://www.path.org/publications/files/TS_opt_unplugged_viet_br.pdf. Accessed July 10, 2013.
Rajgopal, J., Connor, D. L., Assi, T. M., Norman, B. A., Chen, S. I., Bailey, R. R., Long, A. R., Wateska, A. R., Bacon, K. M., Brown, S. T., Burke, D. S., & Lee, B. Y. (2011). The optimal number of routine vaccines to order at health clinics in low or middle income countries. Vaccine, 29(33), 5512–5518.
Savsu (2013). Nano-Q 14 series. http://www.savsu.com/savsunano-q.html. Accessed July 10, 2013.
Stack, M. L., Ozawa, S., Bishai, D. M., Mirelman, A., Tam, Y., Niessen, L., Walker, D. G., & Levine, O. S. (2011). Estimated economic benefits during the ‘decade of vaccines’ include treatment savings, gains in labor productivity. Health Affairs, 30(6), 1021–1028.
TrueEnergy (2013). Sure chill. http://www.trueenergy.com/surechill.aspx. Accessed July 10, 2013.
Village Reach (2012). Personal communication with Village Reach, April 2012.
WHO-1 (2009). State of the world’s vaccines and immunization (3rd ed.). World Health Organization. http://whqlibdoc.who.int/publications/2009/9789241563864_eng.pdf. Accessed July 10, 2013.
WHO-2 (2006). Temperature sensitivity of vaccines. World Health Organization. http://whqlibdoc.who.int/hq/2006/WHO_IVB_06.10_eng.pdf. Accessed July 10, 2013.
WHO-3 (2012). PQS catalogue > prequalified Devices and equipment. World Health Organization. http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/categorylist.aspx?cat_type=device. Accessed July 10, 2013.
WHO-4 (2000). The use of opened multi-dose vials vaccine in subsequent immunization sessions. World Health Organization. https://apps.who.int/vaccines-access/vacman/mdvp/WHO00.09doc.pdf. Accessed July 10, 2013.
WHO-5 (2002). Getting started with vaccine vial monitors. World Health Organization. http://whqlibdoc.who.int/hq/2002/WHO_V&B_02.35.pdf. Accessed July 10, 2013.
WHO-6 (2011). Comprehensive multi-annual plan: expanded program on vaccination, Niger. World Health Organization. http://www.who.int/immunization_financing/countries/cmyp/Niger_cMYP_doc.pdf. Accessed July 10, 2013.
WHO-7 (2009). Introduction of rotavirus vaccines into national immunization programmes: management manual, including operational information for health workers. http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.09_eng.pdf. Accessed July 10, 2013.
WHO-8 (2011). Vaccine management and logistics: vaccine volume calculator. http://www.who.int/immunization_delivery/systems_policy/logistics/en/index4.html. Accessed July 10, 2013.
WHO-9 (2013). WHO vaccine-preventable diseases: monitoring system: 2013 global summary. http://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria[country]=NER. Accessed July 10, 2013.
Acknowledgements
This study was supported by the Vaccine Modeling Initiative (VMI), funded by the Bill and Melinda Gates Foundation, and the National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS) grant 1U54GM088491-0109. The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review, or approval of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, SI., Norman, B.A., Rajgopal, J. et al. Passive cold devices for vaccine supply chains. Ann Oper Res 230, 87–104 (2015). https://doi.org/10.1007/s10479-013-1502-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10479-013-1502-5